跳至主要内容
临床试验/CTRI/2022/04/042336
CTRI/2022/04/042336尚未招募2 期

Role of Khanda Kushmanda Avaleha and Kutajadi Rasakriya in the management of Asrugdara with special reference to Abnormal Uterine Bleeding - A randomised comparative clinical study

ational Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients complaining of Asá¹?gdarawith any two of the following features:
  • à¤?तिप�?राà¤?�?र�?यà¥?णà¤? [Heavy menstrual bleeding] (amount >80ml) Amount more than 80 ml will be assessed by pictorial blood loss assessment chart score 100.
  • दà¥?र�?à¤?à¤?ालान�?बन�?धà¥?न à¤?त�?à¤?ालम {Prolonged menstrual bleeding} &/or (With the duration of bleeding >7 days)
  • à¤?नà¥?त�?à¤?ाल [Inter menstrual bleeding or Frequent menstrual cycle (interval < 24days)]
  • à¤?न�?यद�?रà¤?�?तलà¤?�?षणात वातपित�?तà¤?फत�?रिदà¥?षà¤? à¤?स�?रà¤?�?दर (features different from normal menstrual blood.)
  • Patients of age group 12 to 50 years.

排除标准

  • Patient having Menopausal bleeding.
  • Patients having bleeding due to abortion and childbirth.
  • Patients having coagulation disorders.
  • Patient having genital malignancy.
  • Patients having STDs.
  • Patients having any severe systemic diseases.
  • Uterine and pelvic pathology like- Polyps, Endometrial Tuberculosis, Fibroid, Adenomyosis, Pelvic inflammatory disease etc.
  • Patients using Intra uterine contraceptive device.
  • Recently vaccinated for Covid-19 {within 3 months}.
  • Bleeding from other than vaginal route.

研究者

相似试验